DUBLIN, Jan. 15, 2016 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/lrmlg8/successful) has announced the addition of the "Successful Medical Writing (Barcelona, Spain - April 5-7, 2016)" conference to their offering.
Success in the pharmaceutical industry depends on the speed and efficiency of new drug approvals. This process largely relies on the quality of documentation submitted to the regulatory authorities, and a high standard of medical writing plays a vital role in ensuring success. This intensive practical medical writing course will benefit participants by enabling them to achieve this standard.
Aims and Objectives
This intensive and interactive course combines lectures with practical exercises to provide a thorough introduction to the basics of medical writing that goes beyond the usual overview' courses. It will provide in-depth training in general writing and data presentation skills, and specifically in the kind of documents most frequently encountered in clinical research. Participants will learn both the theoretical and practical aspects of writing for regulatory authorities as well as the sensible use of international guidelines, standards and useful writing tips. Many illustrative examples will be used, drawn from the seminar leaders' wide experience of the pharmaceutical industry
Dr. Barry Drees holds a BSc in molecular biology from the University of California, Santa Barbara and a PhD in Genetics at University of California, San Francisco. After working as a postdoctoral fellow of the American Cancer Society at the University of Freiburg, Germany, he joined Hoechst AG (later Aventis) Frankfurt in 1989 as a medical writer, and was Manager, Medical Writing Phase I-IIa at Aventis Pharma (now Sanofi) in Frankfurt. He is past president of EMWA and is former Editor-in-Chief of The Write Stuff, the Journal of the European Medical Writers Association and Senior Partner at Trilogy Writing & Consulting.
Alistair Reeves holds a BA in applied languages (German, French and Spanish) after studying in London, Tübingen and Amiens. After a period in medical market research, he joined the pharmaceutical industry in 1979 where he worked as a medical translator, followed by successive positions as a medical writer in regulatory affairs and as standards manager (specialising in the design of case report forms and standardisation). This was followed by a period in document management and publishing. In 2002 he founded Ascribe Medical Writing and Translation, based in Wiesbaden, Germany, and besides now focussing on editing and rewriting texts in English by non-native speakers, he gives numerous training events throughout Europe on the use of English in medical and pharmaceutical documentation.
Stephen de Looze
Dr Stephen de Looze holds an MA in biochemistry from the University of Oxford and a PhD in biochemistry from the University of Freiburg, where he was a fellow of the Alexander von Humboldt Foundation. He joined Hoechst AG in Frankfurt in 1985 to establish the Medical Writing department and held the post of Head of Medical Writing at Aventis Pharma (formerly Hoechst AG) until the end of 2001. He was Director of Medical Writing and Electronic Publishing at Accovion GmbH in Eschborn (Frankfurt) from 2002-2013, and is now a freelance consultant in Medical Writing. He has served EMWA on the Education Committee since 2000, and was elected Education Officer 2001-2003 and 2007-2011. He sat on international committees under the auspices of the European Federation of Pharmaceutical industries and Associations for ICH E3 Structure and Content of Clinical Study Reports and ICH M4 The Common Technical Document.
For more information visit
Laura Wood, +353-1-481-1716, email@example.com
SOURCE Research and Markets